Unknown OBSERVATIONAL NCT05976594

Long-term Effectiveness of a Recombinant Hepatitis E Vaccine

Long-term Effectiveness of a Recombinant Hepatitis E Vaccine: a Test-negative Design Study

Sponsor: Dongtai Center for Disease Control and Prevention

Interventions serology and virology detection of hepatitis E virus

Updated 4 times since 2023 Last updated: Aug 12, 2023 Started: Aug 12, 2023 Primary completion: Jul 1, 2025 Completion: Jul 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hepatitis E and is currently ongoing. Dongtai Center for Disease Control and Prevention leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Oct 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dongtai Center for Disease Control and Prevention
Dongtai Hospital of Traditional Chinese Medicine
Dongtai People's Hospital
Xiamen University

Data source: Xiamen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dongtai, China